The North America asparaginase market is expected to grow from US$ 267.71 million in 2022 to US$ 660.94 million by 2028; it is estimated to grow at a CAGR of 16.3% from 2022 to 2028.

Rising Application of Asparaginase in Pharmaceutical & Food Industries

The pharmaceutical & food industries across North America have developed at a significant rate and witnessed various developments to maintain the high quality of food and pharmaceutical products. Nowadays, manufacturers are focusing on the nutritional quantity of food. Asparaginase is the main amino acid responsible for the reduction of sugar in fried and baked foods, which are condensed with carbonyl sources. As a result, the consumption of such fried and baked foods has substantially increased across the region. Moreover, the rising application of asparaginase is boosting the demand for food products and pharmaceuticals, which is driving the North America asparaginase market .

Market Overview

The North America asparaginase market is segmented into the US, Canada, and Mexico. The market growth is mainly attributed to the rising prevalence of leukemia and lymphoma in the region. Further, the US accounts for the largest share of the asparaginase market. According to Leukemia & Lymphoma Society, in 2021, 186,400 people in the US were diagnosed with lymphoma, leukemia, and myeloma. Lymphoma and leukemia are common among children and the adolescent population. The high prevalence rate among a large population has created a demand for effective treatment, which has increased the use of asparaginase. As a result, the survival rates for leukemia and lymphoma have increased in the country. Thus, the rising need for treatment options for leukemia and lymphoma has created the demand for asparaginase, which is driving the market growth in the country.

North America Asparaginase Market Revenue and Forecast to 2028 (US$ Million)

North America Asparaginase Market Segmentation

The North America asparaginase market is segmented on the basis of type, application, end-use industry, and country.

Based on type, the North America asparaginase market is segmented into escherichia coli, erwinia chrysanthemi, pegylated, and others. The escherichia coli segment held the largest market share in 2022. Based on application, the North America asparaginase market is segmented into therapeutic, food processing, and others. The therapeutic segment held the largest market share in 2022. The therapeutic segment is further segmented into acute lymphoblastic leukemia, lymphoblastic lymphoma, and others. Based on end-use industry, the North America asparaginase market is bifurcated into healthcare and food manufacturing. The healthcare segment held a larger market share in 2022. Based on country, the North America asparaginase market is categorized into the US, Canada, and Mexico. Further, the US dominated the market in 2022. Biovendor, LLC; Changzhou Qianhong Biopharma Co Ltd; Creative Enzymes; Jazz Pharmaceuticals, Inc.; medac GMBH; Servier Pharmaceuticals LLC; Taj Pharmaceuticals Limited; and United Biotech (P) Limited are the leading companies operating in the North America asparaginase market.

TABLE OF CONTENTS

1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Asparaginase Market – By Type
1.3.2 North America Asparaginase Market – By Application
1.3.3 North America Asparaginase Market – By End-Use Industry
1.3.4 North America Asparaginase Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Asparaginase Market – Market Landscape
4.1 Overview
4.2 North America PEST Analysis
4.3 Experts Opinion
5. North America Asparaginase Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing Incidences of Leukemia and Increasing Usage Application
5.1.2 Rapid Growth of the Pharmaceutical and Food Industry
5.2 Market Restraints
5.2.1 Side Effects Associated With Use of Asparaginase
5.3 Market Opportunities
5.3.1 New Product Launches and Approvals
5.3.2
5.4 Future Trends
5.4.1 Increase in R&D Activities and Investment by Market Players
5.5 Impact Analysis
6. Asparaginase Market– North America Analysis
6.1 North America Asparaginase Market Revenue Forecasts and Analysis
7. North America Asparaginase Market Analysis – By Type
7.1 Overview
7.2 By Type: North America Market Revenue and Forecast Analysis (US$ Million)
7.2.1 Escherichia Coli
7.2.1.1 Overview
7.2.1.2 Escherichia coli Market Revenue and Forecast to 2028 (US$ Million)
7.2.2 Erwinia Chrysanthemi
7.2.2.1 Overview
7.2.2.2 Erwinia Chrysanthemi Market Revenue and Forecast to 2028 (US$ Million)
7.2.3 Pegylated
7.2.3.1 Overview
7.2.3.2 Pegylated Market Revenue and Forecast to 2028 (US$ Million)
7.2.4 Others
7.2.4.1 Overview
7.2.4.2 Others Market Revenue and Forecast to 2028 (US$ Million)
8. North America Asparaginase Market Analysis – By Application
8.1 Overview
8.2 By Application: North America Market Revenue and Forecast Analysis (US$ Million)
8.2.1 Therapeutic
8.2.1.1 Overview
8.2.1.2 Therapeutic Market Revenue and Forecast to 2028 (US$ Million)
8.2.1.3 Acute Lymphoblastic Leukaemia (ALL)
8.2.1.3.1 Acute lymphoblastic leukemia Market Revenue and Forecast to 2028 (US$ Million)
8.2.1.4 Lymphoblastic Lymphoma (LBL)
8.2.1.4.1 Lymphoblastic lymphoma Market Revenue and Forecast to 2028 (US$ Million)
8.2.1.5 Others
8.2.1.5.1 Others Market Revenue and Forecast to 2028 (US$ Million)
8.2.2 Food Processing
8.2.2.1 Overview
8.2.2.2 Food Processing Market Revenue and Forecast to 2028 (US$ Million)
8.2.3 Others
8.2.3.1 Overview
8.2.3.2 Others Market Revenue and Forecast to 2028 (US$ Million)
9. North America Asparaginase Market Analysis – By End-use Industry
9.1 By End-Use: North America Market Revenue and Forecast Analysis (US$ Million)
9.1.1 Healthcare
9.1.1.1 Overview
9.1.1.2 Healthcare Market Revenue and Forecast to 2028 (US$ Million)
9.1.2 Food Manufacturing
9.1.2.1 Overview
9.1.2.2 Food Manufacturing Market Revenue and Forecast to 2028 (US$ Million)
10. North America Asparaginase Market – Country Analysis
10.1 Overview
10.1.1 North America: Asparaginase Market, by Country, 2021 & 2028 (%)
10.1.1.1 US: Asparaginase Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.1.1.1.1 Overview
10.1.1.1.2 US: Asparaginase Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.1.1.1.3 US: Asparaginase Market, by Type, 2019–2028 (US$ ‘Million)
10.1.1.1.4 US: Asparaginase Market, by Application, 2019–2028 (US$ ‘Million)
10.1.1.1.4.1 US: Asparaginase Market, by Therapeutic Application, 2019–2028 (US$ ‘Million)
10.1.1.1.5 US: Asparaginase Market, by End Use Industry, 2019–2028 (US$ ‘Million)
10.1.1.2 Canada: Asparaginase Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.1.1.2.1 Overview
10.1.1.2.2 Canada: Asparaginase Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.1.1.2.3 Canada: Asparaginase Market, by Type, 2019–2028 (US$ ‘Million)
10.1.1.2.4 Canada: Asparaginase Market, by Application, 2019–2028 (US$ ‘Million)
10.1.1.2.4.1 Canada: Asparaginase Market, by Therapeutic Application, 2019–2028 (US$ ‘Million)
10.1.1.2.5 Canada: Asparaginase Market, by End Use Industry, 2019–2028 (US$ ‘Million)
10.1.1.3 Mexico: Asparaginase Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.1.1.3.1 Overview
10.1.1.3.2 Mexico: Asparaginase Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.1.1.3.3 Mexico: Asparaginase Market, by Type, 2019–2028 (US$ ‘Million)
10.1.1.3.4 Mexico: Asparaginase Market, by Application, 2019–2028 (US$ ‘Million)
10.1.1.3.4.1 Mexico: Asparaginase Market, by Therapeutic Application, 2019–2028 (US$ ‘Million)
10.1.1.3.5 Mexico: Asparaginase Market, by End Use Industry, 2019–2028 (US$ ‘Million)
11. Industry Landscape
11.1 Overview
11.2 Inorganic Growth Strategies
11.2.1 Overview
11.3 Organic Growth Strategies
11.3.1 Overview
12. Company Profiles
12.1 Servier Pharmaceuticals LLC
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Biovendor, LLC
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Creative Enzymes
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Taj Pharmaceuticals Limited
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.5 medac GMBH
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Jazz Pharmaceuticals, Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Changzhou Qianhong Biopharma Co Ltd
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 United Biotech (P) Limited
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms

LIST OF TABLES

Table 1. North America Asparaginase Market– Revenue and Forecast to 2028 (US$ Mn)
Table 2. US: Asparaginase Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 3. US: Asparaginase Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)
Table 4. US: Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ ‘Million)
Table 5. US: Asparaginase Market, by End Use Industry – Revenue and Forecast to 2028 (US$ ‘Million)
Table 6. Canada: Asparaginase Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 7. Canada: Asparaginase Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)
Table 8. Canada: Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ ‘Million)
Table 9. Canada: Asparaginase Market, by End Use Industry – Revenue and Forecast to 2028 (US$ ‘Million)
Table 10. Mexico: Asparaginase Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 11. Mexico: Asparaginase Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)
Table 12. Mexico: Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ ‘Million)
Table 13. Mexico: Asparaginase Market, by End Use Industry – Revenue and Forecast to 2028 (US$ ‘Million)
Table 14. Recent Inorganic Growth Strategies
Table 15. Recent Organic Growth Strategies
Table 16. Glossary of Terms

LIST OF FIGURES

Figure 1. North America Asparaginase Market Segmentation
Figure 2. North America Asparaginase Market Segmentation, by Country
Figure 3. North America Asparaginase Market Overview
Figure 4. North America Asparaginase Market, By Type
Figure 5. North America Asparaginase Market, By Country
Figure 7. North America: PEST Analysis
Figure 8. Experts Opinion
Figure 9. North America Asparaginase Market Impact Analysis of Drivers and Restraints
Figure 10. North America Asparaginase Market – Revenue Forecasts and Analysis
Figure 11. By Type: North America Market Analysis and Forecast 2021 and 2028 (%)
Figure 12. North America Escherichia coli Market Revenue and Forecast to 2028 (US$ Million)
Figure 13. North America Erwinia Chrysanthemi Market Revenue and Forecast to 2028 (US$ Million)
Figure 14. North America Pegylated Market Revenue and Forecast to 2028 (US$ Million)
Figure 15. North America Others Market Revenue and Forecast to 2028 (US$ Million)
Figure 16. By Application: North America Market Analysis and Forecast 2021 and 2028 (%)
Figure 17. North America Therapeutic Market Revenue and Forecast to 2028 (US$ Million)
Figure 18. North America Acute Lymphoblastic Leukemia Market Revenue and Forecast to 2028 (US$ Million)
Figure 19. North America Lymphoblastic lymphoma Market Revenue and Forecast to 2028 (US$ Million)
Figure 20. North America Others Market Revenue and Forecast to 2028 (US$ Million)
Figure 21. North America Food Processing Market Revenue and Forecast to 2028 (US$ Million)
Figure 22. North America Others Market Revenue and Forecast to 2028 (US$ Million)
Figure 23. By End-Use: North America Market Analysis and Forecast 2021 and 2028 (%)
Figure 24. North America Healthcare Market Revenue and Forecast to 2028 (US$ Million)
Figure 25. North America Food Manufacturing Market Revenue and Forecast to 2028 (US$ Million)
Figure 26. North America: Asparaginase Market, by Key Country – Revenue (2021) (US$ ‘Million)
Figure 27. North America: Asparaginase Market, by Country, 2021 & 2028 (%)
Figure 28. US: Asparaginase Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 29. Canada: Asparaginase Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 30. Mexico: Asparaginase Market – Revenue and Forecast to 2028 (US$ ‘Million)

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America asparaginase market.
● Highlights key business priorities in order to assist companies to realign their business strategies
● The key findings and recommendations highlight crucial progressive industry trends in the North America asparaginase market, thereby allowing players across the value chain to develop effective long-term strategies
● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
● Scrutinize in-depth North America market trends and outlook coupled with the factors driving the asparaginase market, as well as those hindering it
● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

The List of Companies – North America Asparaginase Market

● Biovendor, LLC
● Changzhou Qianhong Biopharma Co Ltd
● Creative Enzymes
● Jazz Pharmaceuticals, Inc.
● medac GMBH
● Servier Pharmaceuticals LLC
● Taj Pharmaceuticals Limited  
● United Biotech (P) Limited

At 16.3% CAGR, the North America Asparaginase Market is speculated to be worth US$ 660.94 million by 2028, says The Insight Partners

According to The Insight Partners’ research, the North America asparaginase market was valued at US$ 267.71 million in 2022 and is expected to reach US$ 660.94 million by 2028, registering an annual growth rate of 16.3% from 2022 to 2028. Rising incidences of leukemia and increasing usage application and significant growth of pharmaceutical and food industry are the critical factors attributed to the market expansion.

Asparaginase is an enzyme, derived mostly from bacteria, and has wide application in the food and pharmaceutical industry. Asparaginase is widely used to treat various conditions, such as acute myeloid leukemia, acute lymphoblastic leukemia, non-Hodgkin’s lymphoma, and other diseases. Over the period, the prevalence of such diseases has increased significantly, creating a demand for effective treatment options. L-asparaginase is an important chemotherapeutic agent used to treat lymphoma and leukemia. L-asparaginase breakdown asparagine from blood serum, leading to the death of tumor cells due to the lack of an essential factor for protein synthesis. However, healthy cells are not affected as they can produce asparagine using L-asparagine synthetase, which is present in adequate quantity. Moreover, it is also found to be effective in preventing metastasis from solid tumors. Asparaginase is a naturally occurring substance that is present in mammals, birds, yeast, plants, and different types of bacteria but Enterobacteriaceae family microorganisms are one of the primary sources of L-asparaginase production. Additionally, there is various research going on for the expansion of its application area in different industries, such as nanomedicine, biomedical engineering, and many more, which is contributing to the market growth. Furthermore, increasing allergic reactions from E. coli, derived L-asparaginase has increased the use of E. chrysanthemi derived L-Asparaginase. There are new production methods for asparaginase are developing, which include new bacterial strains, such as Pseudomonas fluorescens, Escherichia coli, Serratia marcescens, Erwinia carotovora, Saccharomyces cerevisiae, and Proteus vulgaris. A few genres of fungi are also used, such as Penicillium, Aspergillus, and Fusarium. These factors are boosting the asparaginase market significantly.

On the contrary, side effects associated with use of asparaginase hurdles the growth of North America asparaginase market.

Based on type, the North America asparaginase market is segmented into escherichia coli, erwinia chrysanthemi, pegylated, and others. The escherichia coli segment held 49.0% market share in 2022, amassing US$ 131.20 million. It is projected to garner US$ 332.20 million by 2028 to expand at 16.7% CAGR during 2022–2028. Based on application, the North America asparaginase market is segmented into therapeutic, food processing, and others. The therapeutic segment held 60.6% market share in 2022, amassing US$ 162.24 million. It is projected to garner US$ 408.57 million by 2028 to expand at 16.6% CAGR during 2022–2028. The therapeutic segment is further classified into acute lymphoblastic leukemia, lymphoblastic lymphoma, and others. Based on end-use industry, the North America asparaginase market is bifurcated into healthcare and food manufacturing. The healthcare segment held 59.4% market share in 2022, amassing US$ 159.07 million. It is projected to garner US$ 395.76 million by 2028 to expand at 16.4% CAGR during 2022–2028. Based on country, the North America asparaginase market has been categorized into the US, Canada, and Mexico. Our regional analysis states that the US captured 85.0% market share in 2022. It was assessed at US$ 227.47 million in 2022 and is likely to hit US$ 569.31 million by 2028, exhibiting a CAGR of 16.5% during the forecast period. Key players dominating the North America asparaginase market are Biovendor, LLC; Changzhou Qianhong Biopharma Co Ltd; Creative Enzymes; Jazz Pharmaceuticals, Inc.; medac GMBH; Servier Pharmaceuticals LLC; Taj Pharmaceuticals Limited; and United Biotech (P) Limited among others.

In May 2021, Jazz Pharmaceuticals acquired GW pharmaceutical company to enhance the R&D capabilities. In April 2021, Servier completed acquisition of Agios Pharmaceuticals’ $2 billion plus royalties which include commercial, clinical, and research-stage oncology portfolio. This acquisition strengthens Servier’s commercial presence in the U.S. malignant hematology market and provides the potential for long-term growth into the solid tumor space.